Century Therapeutics Inc (NASDAQ: IPSC) kicked off on Tuesday, up 3.28% from the previous trading day, before settling in for the closing price of $0.6. Over the past 52 weeks, IPSC has traded in a range of $0.34-$1.83.
A company in the Healthcare sector has jumped its sales by 18.46% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 93.01%. With a float of $39.65 million, this company’s outstanding shares have now reached $86.32 million.
Century Therapeutics Inc (IPSC) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Century Therapeutics Inc is 54.10%, while institutional ownership is 23.58%. The most recent insider transaction that took place on Sep 08 ’25, was worth 132. In this transaction SVP Finance & Operations of this company sold 263 shares at a rate of $0.50, taking the stock ownership to the 405,423 shares. Before that another transaction happened on Sep 08 ’25, when Company’s President and CEO sold 488 for $0.50, making the entire transaction worth $244. This insider now owns 3,268,909 shares in total.
Century Therapeutics Inc (IPSC) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.37 earnings per share (EPS), higher than consensus estimate (set at -0.45) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.74% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Take a look at Century Therapeutics Inc’s (IPSC) current performance indicators. Last quarter, stock had a quick ratio of 10.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.79 million. That was better than the volume of 0.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 84.39%.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 70.29%, which indicates a significant decrease from 90.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0350 in the past 14 days, which was lower than the 0.0362 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5263, while its 200-day Moving Average is $0.5888. However, in the short run, Century Therapeutics Inc’s stock first resistance to watch stands at $0.6347. Second resistance stands at $0.6496. The third major resistance level sits at $0.6692. If the price goes on to break the first support level at $0.6002, it is likely to go to the next support level at $0.5806. Assuming the price breaks the second support level, the third support level stands at $0.5657.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
The company with the Market Capitalisation of 53.54 million has total of 86,389K Shares Outstanding. Its annual sales at the moment are 6,590 K in contrast with the sum of -126,570 K annual income. Company’s last quarter sales were recorded 109,160 K and last quarter income was 76,560 K.
